Chemours (CC) PT Lowered to $54 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Chemours (CC) PT Raised to $70 at BMO Capital; Remains Top Pick
May 8, 2018 9:26 AM EDTBMO Capital raised its price target on Chemours (NYSE: CC) to $70.00 (from $68.00) while maintaining a Outperform rating.
Analyst John McNulty commented, "We continue to believe in the TiO2 story (elongated cycle, tight supply, price-value stabilization) but see room for Fluoro to exceed... More
Chemours (CC) PT Raised to $69 at Citi
May 8, 2018 6:12 AM EDTCiti raised its price target on Chemours (NYSE: CC) to $69.00 (from $66.00) while maintaining a Buy rating.
... More